Mast cells partially contribute to mucosal adjuvanticity of surfactin in mice

Abstract Introduction Surfactin (SF) is a cyclic lipopeptide that has potent mucosal adjuvant properties. However, immunological mechanisms of SF adjuvant action have not yet been elucidated. As some cyclic lipopeptides, such as polymyxin, can stimulate histamine release from mast cells, we hypothes...

Full description

Bibliographic Details
Main Authors: Naoto Yoshino, Ryosuke Takeshita, Hanae Kawamura, Yutaka Sasaki, Masahiro Kagabu, Toru Sugiyama, Yasushi Muraki, Shigehiro Sato
Format: Article
Language:English
Published: Wiley 2018-03-01
Series:Immunity, Inflammation and Disease
Subjects:
Online Access:https://doi.org/10.1002/iid3.204
id doaj-db5a2ecf8a3545eea95726557cc65609
record_format Article
spelling doaj-db5a2ecf8a3545eea95726557cc656092020-11-25T03:10:51ZengWileyImmunity, Inflammation and Disease2050-45272018-03-016111712710.1002/iid3.204Mast cells partially contribute to mucosal adjuvanticity of surfactin in miceNaoto Yoshino0Ryosuke Takeshita1Hanae Kawamura2Yutaka Sasaki3Masahiro Kagabu4Toru Sugiyama5Yasushi Muraki6Shigehiro Sato7Division of Infectious Diseases and ImmunologyDepartment of Microbiology, School of Medicine, Iwate Medical UniversityIwateJapanDepartment of Obstetrics and GynecologySchool of Medicine, Iwate Medical UniversityIwateJapanDepartment of Obstetrics and GynecologySchool of Medicine, Iwate Medical UniversityIwateJapanDivision of Infectious Diseases and ImmunologyDepartment of Microbiology, School of Medicine, Iwate Medical UniversityIwateJapanDepartment of Obstetrics and GynecologySchool of Medicine, Iwate Medical UniversityIwateJapanDepartment of Obstetrics and GynecologySchool of Medicine, Iwate Medical UniversityIwateJapanDivision of Infectious Diseases and ImmunologyDepartment of Microbiology, School of Medicine, Iwate Medical UniversityIwateJapanDivision of Infectious Diseases and ImmunologyDepartment of Microbiology, School of Medicine, Iwate Medical UniversityIwateJapanAbstract Introduction Surfactin (SF) is a cyclic lipopeptide that has potent mucosal adjuvant properties. However, immunological mechanisms of SF adjuvant action have not yet been elucidated. As some cyclic lipopeptides, such as polymyxin, can stimulate histamine release from mast cells, we hypothesized that mast cell activation is critical for SF adjuvanticity. Methods/Results We observed that following intranasal immunization with ovalbumin (OVA) plus SF, the titers of the OVA‐specific antibody (Ab) in the mucosal secretions and plasma of mast cell‐deficient mice were significantly lower than those in congenic normal mice, although OVA‐specific Ab did not entirely disappear from mast cell‐deficient mice. SF induced degranulation of mast cells and release of histamine in vitro. To investigate whether SF stimulated mast cells in vivo, we measured body temperature of mice immunized intranasally with OVA plus SF because histamine level affects body temperature. Following immunizations, body temperature of immunized congenic normal mice transiently decreased, whereas body temperature of mast cell‐deficient mice did not change. Plasma levels of OVA‐specific IgE Ab were not significantly different in mast cell‐deficient and congenic normal mice. These findings suggest that SF directly affected mast cells in an IgE Ab‐independent fashion. Furthermore, we analyzed the effects of SF on MC/9 mast cells cultured in vitro. MC/9 cells stimulated by SF released not only histamine but also leukotriene B4 and prostaglandin D2. Moreover, SF up‐regulated mRNA expression levels of Tnf, Ccr5, and Il4 genes in mast cells. These cytokines may play a facilitating role in OVA‐specific immune responses in mice. Conclusion Overall, our results showed that mast cell activation partially mediated SF adjuvanticity.https://doi.org/10.1002/iid3.204adjuvantsbody temperaturehistaminelipopeptidesmast cells
collection DOAJ
language English
format Article
sources DOAJ
author Naoto Yoshino
Ryosuke Takeshita
Hanae Kawamura
Yutaka Sasaki
Masahiro Kagabu
Toru Sugiyama
Yasushi Muraki
Shigehiro Sato
spellingShingle Naoto Yoshino
Ryosuke Takeshita
Hanae Kawamura
Yutaka Sasaki
Masahiro Kagabu
Toru Sugiyama
Yasushi Muraki
Shigehiro Sato
Mast cells partially contribute to mucosal adjuvanticity of surfactin in mice
Immunity, Inflammation and Disease
adjuvants
body temperature
histamine
lipopeptides
mast cells
author_facet Naoto Yoshino
Ryosuke Takeshita
Hanae Kawamura
Yutaka Sasaki
Masahiro Kagabu
Toru Sugiyama
Yasushi Muraki
Shigehiro Sato
author_sort Naoto Yoshino
title Mast cells partially contribute to mucosal adjuvanticity of surfactin in mice
title_short Mast cells partially contribute to mucosal adjuvanticity of surfactin in mice
title_full Mast cells partially contribute to mucosal adjuvanticity of surfactin in mice
title_fullStr Mast cells partially contribute to mucosal adjuvanticity of surfactin in mice
title_full_unstemmed Mast cells partially contribute to mucosal adjuvanticity of surfactin in mice
title_sort mast cells partially contribute to mucosal adjuvanticity of surfactin in mice
publisher Wiley
series Immunity, Inflammation and Disease
issn 2050-4527
publishDate 2018-03-01
description Abstract Introduction Surfactin (SF) is a cyclic lipopeptide that has potent mucosal adjuvant properties. However, immunological mechanisms of SF adjuvant action have not yet been elucidated. As some cyclic lipopeptides, such as polymyxin, can stimulate histamine release from mast cells, we hypothesized that mast cell activation is critical for SF adjuvanticity. Methods/Results We observed that following intranasal immunization with ovalbumin (OVA) plus SF, the titers of the OVA‐specific antibody (Ab) in the mucosal secretions and plasma of mast cell‐deficient mice were significantly lower than those in congenic normal mice, although OVA‐specific Ab did not entirely disappear from mast cell‐deficient mice. SF induced degranulation of mast cells and release of histamine in vitro. To investigate whether SF stimulated mast cells in vivo, we measured body temperature of mice immunized intranasally with OVA plus SF because histamine level affects body temperature. Following immunizations, body temperature of immunized congenic normal mice transiently decreased, whereas body temperature of mast cell‐deficient mice did not change. Plasma levels of OVA‐specific IgE Ab were not significantly different in mast cell‐deficient and congenic normal mice. These findings suggest that SF directly affected mast cells in an IgE Ab‐independent fashion. Furthermore, we analyzed the effects of SF on MC/9 mast cells cultured in vitro. MC/9 cells stimulated by SF released not only histamine but also leukotriene B4 and prostaglandin D2. Moreover, SF up‐regulated mRNA expression levels of Tnf, Ccr5, and Il4 genes in mast cells. These cytokines may play a facilitating role in OVA‐specific immune responses in mice. Conclusion Overall, our results showed that mast cell activation partially mediated SF adjuvanticity.
topic adjuvants
body temperature
histamine
lipopeptides
mast cells
url https://doi.org/10.1002/iid3.204
work_keys_str_mv AT naotoyoshino mastcellspartiallycontributetomucosaladjuvanticityofsurfactininmice
AT ryosuketakeshita mastcellspartiallycontributetomucosaladjuvanticityofsurfactininmice
AT hanaekawamura mastcellspartiallycontributetomucosaladjuvanticityofsurfactininmice
AT yutakasasaki mastcellspartiallycontributetomucosaladjuvanticityofsurfactininmice
AT masahirokagabu mastcellspartiallycontributetomucosaladjuvanticityofsurfactininmice
AT torusugiyama mastcellspartiallycontributetomucosaladjuvanticityofsurfactininmice
AT yasushimuraki mastcellspartiallycontributetomucosaladjuvanticityofsurfactininmice
AT shigehirosato mastcellspartiallycontributetomucosaladjuvanticityofsurfactininmice
_version_ 1724656963971710976